Ascend Wellness Holdings (AAWH) Intangibles (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Intangibles came in at $189.5 million in Q1 2026, down 10.18% year-on-year from $211.0 million in Q1 2025, and down 3.35% quarter-over-quarter from $196.1 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Intangibles (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Intangibles history runs 7 years deep, the most recent figure standing at $189.5 million for Q1 2026.
- On a quarterly basis, Intangibles fell 10.18% year-over-year to $189.5 million in Q1 2026; TTM through Mar 2026 was $189.5 million, a 10.18% decrease from a year earlier, with the FY2025 full-year figure at $196.1 million, down 4.59% from the prior year.
- Intangibles declined to $189.5 million in Q1 2026 per AAWH's latest filing, from $196.1 million in the prior quarter.
- Across five years, Intangibles topped out at $227.6 million in Q3 2023 and bottomed at $3.5 million in Q3 2025.
- The 5-year median for Intangibles is $211.0 million (2025), against an average of $186.1 million.
- Across the five-year window, Intangibles soared 275.11% in 2023 and sank 98.35% in 2025, its largest moves.
- Year by year, Intangibles stood at $221.1 million in 2022, then rose by 0.16% to $221.5 million in 2023, then dropped by 7.2% to $205.5 million in 2024, then retreated by 4.59% to $196.1 million in 2025, then slipped by 3.35% to $189.5 million in 2026.
- Per Business Quant, the three latest AAWH Intangibles figures stand at $189.5 million (Q1 2026), $196.1 million (Q4 2025), and $3.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 189.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 189.50 Mn |
| Dec 31, 2025 | 196.07 Mn |
| Sep 30, 2025 | 3.51 Mn |
| Jun 30, 2025 | 206.70 Mn |
| Mar 31, 2025 | 210.99 Mn |
| Dec 31, 2024 | 205.50 Mn |
| Sep 30, 2024 | 212.19 Mn |
| Jun 30, 2024 | 216.15 Mn |
| Mar 31, 2024 | 218.36 Mn |
| Dec 31, 2023 | 221.45 Mn |
| Sep 30, 2023 | 227.57 Mn |
| Jun 30, 2023 | 220.73 Mn |
| Mar 31, 2023 | 214.94 Mn |
| Dec 31, 2022 | 221.09 Mn |
| Sep 30, 2022 | 186.43 Mn |
| Jun 30, 2022 | 155.57 Mn |
| Mar 31, 2022 | 57.30 Mn |
| Dec 31, 2021 | 59.27 Mn |
| Sep 30, 2021 | 50.84 Mn |
| Jun 30, 2021 | 52.51 Mn |